Arti Masturzo, M.D., chief medical officer of CCS, spoke with Managed Healthcare Executive about the differences in coaching and guiding patients with type 1 diabetes compared to type 2.
Managing type 1 diabetes requires precise insulin dosing, carb counting and continuous monitoring.
Unlike type 2 diabetes, which focuses more on diet and exercise, type 1 is much more complex, according to Arti Masturzo, M.D., chief medical officer of CCS.
"With type 1, it is much more surgical and scientific in nature," Masturzo said. "With type 2, it’s more about, ‘Hey, eat this kind of diet. Don’t eat this. Get this extra.’ With type 1, it’s life or death."
She added there is an increased aspect of mental health that goes along with type 1 as it's a disease where folks get diagnosed at a young age — commonly under 18 years — and live with it for the rest of their lives.
However, the disease that was once referred to as "juvenile diabetes" is being detected in older adults who have been living with it undiagnosed.
"It's just a different lifestyle," she said. "So the support is definitely individualized for folks living with type 1 diabetes."
CCS prioritizes clinician-led care, offering hands-on training and virtual coaching through certified diabetes educators and nurses.
Many of these professionals have firsthand experience with type 1 diabetes, allowing them to provide both technical and emotional support.
However, when asked what the biggest reasons are why those with type one diabetes aren't getting the support they need, Masturzo responded by addressing the shortage of endocrinologists.
Results from a survey Masturzo discussed revealed that primary care physicians did not feel adequately trained to manage complex diabetes patients.
She added that 58% of primary care doctors and 85% of endocrinologists said that they felt overwhelmed with the amount of diabetes cases, not just specific to type one, but just in general.
This shortage makes access to specialized care difficult, leaving many primary care physicians overwhelmed.
By providing personalized coaching and education, CCS is working to bridge this gap, by supporting patients and managing their condition effectively.
Digital Twin Technology Enhances Blood Sugar Control in Type 1 Diabetes
June 11th 2025A cloud-based digital twin simulation, coupled with automated insulin delivery, allows patients with diabetes to experiment with their own data on glycemic control in a safe simulation environment before adjusting their system.
Read More
Adult-Onset Type 1 Diabetes Increases Risk of Cardiovascular Disease
June 2nd 2025The risk of major cardiac events was 50% higher in adult-onset type 1 diabetes than in population controls, and the risk of death from diabetic coma or ketoacidosis was seven times as high as those with type 2 diabetes.
Read More
World’s First Immunotherapy Trial for Type 1 Diabetes Is Underway in Australia
May 23rd 2025Led by the University of Queensland’s research facility, Frazer Institute, the trial examining the drug ASITI-201 is the first of its kind in the world and has already dosed its first five participants.
Read More